(Q38974538)

8 September 2017

title

Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma (English)

1 reference

8 September 2017

0 references

Donghua Xu

1

1 reference

8 September 2017

Xiaochen Wang

2

1 reference

8 September 2017

Shushan Yan

3

1 reference

8 September 2017

Yin Yin

4

1 reference

8 September 2017

Jiajie Hou

5

1 reference

8 September 2017

Xuehao Wang

6

1 reference

8 September 2017

Beicheng Sun

7

1 reference

8 September 2017

publication date

18 July 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

10

1 reference

8 September 2017

page(s)

10267-10273

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2302-5

8 September 2017

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Inflammation and liver tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Epidemiology and surveillance of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Pattern recognition receptors: a contemporary view on liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Toll-like receptors: cost or benefit for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

TLR signaling by tumor and immune cells: a double-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Role of Toll-like receptors in gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Tissue-specific mRNA expression profiles of human toll-like receptors and related genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Protein tyrosine phosphatases in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Protein tyrosine phosphatase receptor-type O truncated (PTPROt) regulates SYK phosphorylation, proximal B-cell-receptor signaling, and cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Investigation of NF-κB1 and NF-κBIA gene polymorphism in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

NF-κB and the link between inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2302-5

Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25034527

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The significance of Toll-like receptor 4 (TLR4) expression in patients with chronic hepatitis B.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25034527

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25034527

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-014-2302-5

1 reference

Dimensions Publication ID

8 September 2017

1020668207

0 references

1 reference